Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014662
Filing Date
2024-11-06
Accepted
2024-11-06 16:55:29
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mxct-20240930x10q.htm   iXBRL 10-Q 1619249
2 EX-31.1 mxct-20240930xex31d1.htm EX-31.1 15660
3 EX-31.2 mxct-20240930xex31d2.htm EX-31.2 14908
4 EX-32.1 mxct-20240930xex32d1.htm EX-32.1 7725
5 EX-32.2 mxct-20240930xex32d2.htm EX-32.2 7118
  Complete submission text file 0001558370-24-014662.txt   6139129

Data Files

Seq Description Document Type Size
6 EX-101.SCH mxct-20240930.xsd EX-101.SCH 34824
7 EX-101.CAL mxct-20240930_cal.xml EX-101.CAL 49467
8 EX-101.DEF mxct-20240930_def.xml EX-101.DEF 142149
9 EX-101.LAB mxct-20240930_lab.xml EX-101.LAB 361653
10 EX-101.PRE mxct-20240930_pre.xml EX-101.PRE 258271
63 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20240930x10q_htm.xml XML 992340
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40674 | Film No.: 241431915
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)